Literature DB >> 18993075

Evidence for insertional RNA editing in humans.

Alexandre Zougman1, Piotr Ziółkowski, Matthias Mann, Jacek R Wiśniewski.   

Abstract

Large-scale analysis directly at the protein level holds the promise of uncovering features not apparent or present at the gene level [1-3]. Although mass spectrometry (MS)-based proteomics can now identify and quantify thousands of cellular proteins in large-scale proteomics experiments, much of the peptide information contained in these experiments remains unassigned [4]. Here, we use such information to discover a previously unreported mechanism creating altered protein forms. Linker histones H1 and high-mobility group (HMG) proteins are abundant nuclear proteins that regulate gene expression through modulation of chromatin structure [5-8]. In the high-resolution MS analysis of histone H1 and HMG protein fractions isolated from human cells, we discovered peptides that mapped upstream of the known translation start sites of these genes. No alternative upstream start site exists in the genome, but analysis of Expressed Sequence Tag (EST) databases revealed that these N-terminally extended (ET) proteins are due to in-frame translation of the 5' untranslated region (5'UTR) sequences of the transcripts. The new translation start sites are created by a single uridine insertion between AG, reflecting a previously unreported RNA-editing mechanism. To our knowledge, this is the first report of RNA-insertion editing in humans and may be an example of the type of discoveries possible with modern proteomics methods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18993075     DOI: 10.1016/j.cub.2008.09.059

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  7 in total

Review 1.  Use of proteomics in radiobiological research: current state of the art.

Authors:  Soile Tapio; Sabine Hornhardt; Maria Gomolka; Dariusz Leszczynski; Anton Posch; Stefan Thalhammer; Michael J Atkinson
Journal:  Radiat Environ Biophys       Date:  2010-01-05       Impact factor: 1.925

2.  Systematic investigation of insertional and deletional RNA-DNA differences in the human transcriptome.

Authors:  Cai Chen; Ralf Bundschuh
Journal:  BMC Genomics       Date:  2012-11-13       Impact factor: 3.969

3.  Identification and characterization of a novel ubiquitous nucleolar protein 'NARR' encoded by a gene overlapping the rab34 oncogene.

Authors:  Alexandre Zougman; Matthias Mann; Jacek R Wisniewski
Journal:  Nucleic Acids Res       Date:  2011-05-17       Impact factor: 16.971

4.  Identification of evolutionarily conserved non-AUG-initiated N-terminal extensions in human coding sequences.

Authors:  Ivaylo P Ivanov; Andrew E Firth; Audrey M Michel; John F Atkins; Pavel V Baranov
Journal:  Nucleic Acids Res       Date:  2011-01-25       Impact factor: 16.971

5.  A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses.

Authors:  Matthew P Welberry Smith; Steven L Wood; Alexandre Zougman; Jenny T C Ho; Jianhe Peng; David Jackson; David A Cairns; Andrew J P Lewington; Peter J Selby; Rosamonde E Banks
Journal:  Proteomics       Date:  2011-05-05       Impact factor: 3.984

6.  The UniProtKB guide to the human proteome.

Authors:  Lionel Breuza; Sylvain Poux; Anne Estreicher; Maria Livia Famiglietti; Michele Magrane; Michael Tognolli; Alan Bridge; Delphine Baratin; Nicole Redaschi
Journal:  Database (Oxford)       Date:  2016-02-20       Impact factor: 3.451

7.  Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation.

Authors:  Matthew P Welberry Smith; Alexandre Zougman; David A Cairns; Michelle Wilson; Tobias Wind; Steven L Wood; Douglas Thompson; Michael P Messenger; Andrew Mooney; Peter J Selby; Andrew J P Lewington; Rosamonde E Banks
Journal:  Kidney Int       Date:  2013-06-05       Impact factor: 10.612

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.